Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

NCT07510815 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesotheliomas

Interventions

BIOLOGICAL: EB-MF-CAR-NK-01
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Beijing Biotech